Emergex has entered into an agreement with DEKA Research & Development (‘DEKA’) to assess the compatibility of Emergex’s T cell-priming set-point immunotherapeutic candidates with DEKA’s Intradermal Therapeutic Applicator. The collaboration
Tiziana Life Sciences (NASDAQ:TLSA – Get Free Report) and United Therapeutics (NASDAQ:UTHR – Get Free Report) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, earnings, risk, analyst recommendations, valuation, institutional ownership and profitability. Institutional and Insider Ownership 0.9% of Tiziana […]
United Therapeutics (NASDAQ:UTHR – Get Free Report) and Tiziana Life Sciences (NASDAQ:TLSA – Get Free Report) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their profitability, valuation, earnings, analyst recommendations, risk, institutional ownership and dividends. Institutional & Insider Ownership 94.1% of United […]